Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
52.7M
-
Shares change
-
-166K
-
Total reported value, excl. options
-
$996M
-
Value change
-
-$4.09M
-
Put/Call ratio
-
0.73
-
Number of buys
-
75
-
Number of sells
-
-86
-
Price
-
$18.88
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q1 2024
215 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.7M shares
of 106M outstanding shares and own 49.92% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.9M shares), STATE STREET CORP (4.9M shares), VANGUARD GROUP INC (4.79M shares), FMR LLC (4.78M shares), Woodline Partners LP (2.88M shares), Point72 Asset Management, L.P. (1.91M shares), DIMENSIONAL FUND ADVISORS LP (1.62M shares), Invus Financial Advisors, LLC (1.61M shares), Boxer Capital, LLC (1.6M shares), and AMERIPRISE FINANCIAL INC (1.2M shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.